Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype. [electronic resource]
Producer: 20200922Description: 8505-8510 p. digitalISSN:- 1582-4934
- Animals
- Anticonvulsants -- pharmacology
- Cell Line, Tumor
- Cells, Cultured
- Epilepsy -- drug therapy
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 -- genetics
- Levetiracetam -- pharmacology
- Membrane Glycoproteins -- metabolism
- Mice, Inbred C57BL
- Mice, Knockout
- Mice, Transgenic
- Mutation
- Nerve Tissue Proteins -- metabolism
- Neurites -- drug effects
- Neurons -- drug effects
- PC12 Cells
- Parkinson Disease -- drug therapy
- Protein Binding
- Rats
- Signal Transduction -- drug effects
- Synaptic Vesicles -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.